The Aib-8 substitution replaces the native alanine at position 8 with -aminoisobutyric acid, a non-natural amino acid that completely blocks dipeptidyl peptidase-IV cleavage, the enzymatic step that inactivates native GLP-1 within two minutes of secretion
This triple mechanism distinguishes it from existing approved treatments such as semaglutide (a GLP-1 agonist) or tirzepatide (a dual GIP/GLP-1 agonist)
Next, the At LDOX protein was removed using an Amicon Ultra-4 device (10 kDa cut-off) (Merck Millipore) and the eluent was diluted with 1.375 vol of the same reaction buffer containing 82% H 2 18 O and incubated at 30 C, 1,200 rpm using a 3 mm shaking diameter to achieve 18 O equilibration
Additionally, it is believed to aid in reducing oxidative stress, combating free radicals, and improving energy levels
Dotson CD, Shaw HL, Mitchell BD, Munger SD, Steinle NI
The recommended daily amount should not exceed 10% of the daily kilocalories of the dog's usual diet